tiprankstipranks
Advertisement
Advertisement

INSM Stock Latest News

Insmed Earnings Call Highlights BRINSUPRI-Driven Surge
Company AnnouncementsInsmed Earnings Call Highlights BRINSUPRI-Driven Surge
3d ago
INSM
Analyst Maintains Buy/Overweight Rating and $218 Price Target on Brinsupri’s Strong Q2 Outperformance
PremiumRatings
Analyst Maintains Buy/Overweight Rating and $218 Price Target on Brinsupri’s Strong Q2 Outperformance
3d ago
INSM
Insmed Extends Its Pulmonary Hypertension Push With Long-Term TPIP Study
PremiumCompany Announcements
Insmed Extends Its Pulmonary Hypertension Push With Long-Term TPIP Study
7d ago
INSM
Insmed price target raised to $195 from $185 at Truist
PremiumThe Fly
Insmed price target raised to $195 from $185 at Truist
10d ago
INSM
Insmed price target lowered to $175 from $179 at JPMorgan
PremiumThe Fly
Insmed price target lowered to $175 from $179 at JPMorgan
10d ago
INSM
Insmed price target raised to $218 from $212 at Morgan Stanley
PremiumThe FlyInsmed price target raised to $218 from $212 at Morgan Stanley
13d ago
INSM
Insmed price target raised to $170 from $160 at Evercore ISI
Premium
The Fly
Insmed price target raised to $170 from $160 at Evercore ISI
13d ago
INSM
Insmed price target lowered to $205 from $207 at Guggenheim
Premium
The Fly
Insmed price target lowered to $205 from $207 at Guggenheim
13d ago
INSM
Insmed price target raised to $172 from $166 at UBS
PremiumThe Fly
Insmed price target raised to $172 from $166 at UBS
13d ago
INSM
Insmed price target raised to $169 from $161 at Wells Fargo
PremiumThe Fly
Insmed price target raised to $169 from $161 at Wells Fargo
13d ago
INSM
Insmed (INSM): Brinsupri Outperformance and Raised Sales Guidance Support Buy Rating
PremiumRatings
Insmed (INSM): Brinsupri Outperformance and Raised Sales Guidance Support Buy Rating
13d ago
INSM
Insmed price target raised to $175 from $160 at Jefferies
PremiumThe Fly
Insmed price target raised to $175 from $160 at Jefferies
14d ago
INSM
Matt Phipps Reiterates Buy on Insmed as Brinsupri Outperformance, Raised Guidance and Higher Peak Sales Outlook Strengthen Long-Term Growth Story
PremiumRatingsMatt Phipps Reiterates Buy on Insmed as Brinsupri Outperformance, Raised Guidance and Higher Peak Sales Outlook Strengthen Long-Term Growth Story
14d ago
INSM
Insmed rises 31.9%
Premium
The Fly
Insmed rises 31.9%
14d ago
INSM
Insmed rises 37.1%
Premium
The Fly
Insmed rises 37.1%
14d ago
INSM
Insmed reports Q2 EPS (6c) vs. ($1.70) last year
PremiumThe Fly
Insmed reports Q2 EPS (6c) vs. ($1.70) last year
14d ago
INSM
INSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
INSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
16d ago
INSM
Ritu Baral Reaffirms Buy on Insmed, Raising Price Target from $200 to $243 Ahead of Q2 Preview
PremiumRatings
Ritu Baral Reaffirms Buy on Insmed, Raising Price Target from $200 to $243 Ahead of Q2 Preview
30d ago
INSM
Insmed initiated with an Outperform at BMO Capital
PremiumThe Fly
Insmed initiated with an Outperform at BMO Capital
1M ago
INSM
Insmed: TPIP’s Strong Durability and Risk‑Benefit Profile Support Buy Rating and Unchanged $212 Price Target
PremiumRatingsInsmed: TPIP’s Strong Durability and Risk‑Benefit Profile Support Buy Rating and Unchanged $212 Price Target
1M ago
INSM
Insmed Announces Positive 12-Month TPIP PAH Data
Premium
Company Announcements
Insmed Announces Positive 12-Month TPIP PAH Data
1M ago
8K
INSM
Insmed Maintained at Buy as TPIP Data Underscore Long-Term Growth Potential and Justify Unchanged $214 Price Target
Premium
Ratings
Insmed Maintained at Buy as TPIP Data Underscore Long-Term Growth Potential and Justify Unchanged $214 Price Target
1M ago
INSM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >